The Silencing of N-myc Downstream-Regulated Gene-1 in an Orthotopic Pancreatic Cancer Model Leads to More Aggressive Tumor Growth and Metastases

Kim-Fuchs, Corina; Winterhalder, Sebastian; Winter, Annja; Malinka, Thomas; Born, Diana; Schäfer, Stephan; Keogh-Stroka, Deborah M.; Gloor, Beat; Candinas, Daniel; Angst, Eliane (2014). The Silencing of N-myc Downstream-Regulated Gene-1 in an Orthotopic Pancreatic Cancer Model Leads to More Aggressive Tumor Growth and Metastases. Digestive surgery, 31(2), pp. 135-142. Karger 10.1159/000363065

[img] Text
The Silencing of N-myc Downstream-Regulated.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (350kB) | Request a copy

BACKGROUND: The understanding of molecular mechanisms leading to poor prognosis in pancreatic cancer may help develop treatment options. N-myc downstream-regulated gene-1 (NDRG1) has been correlated to better prognosis in pancreatic cancer. Therefore, we thought to analyze how the loss of NDRG1 affects progression in an orthotopic xenograft animal model of recurrence. METHODS: Capan-1 cells were silenced for NDRG1 (C(sil)) or transfected with scrambled shRNA (C(scr)) and compared for anchorage-dependent and anchorage-independent growth, invasion and tube formation in vitro. In an orthotopic xenograft model of recurrence tumors were grown in the pancreatic tail. The effect of NDRG1 silencing was evaluated on tumor size and metastasis. RESULTS: The silencing of NDRG1 in Capan-1 cells leads to more aggressive tumor growth and metastasis. We found faster cell growth, double count of invaded cells and 1.8-fold increase in tube formation in vitro. In vivo local tumors were 5.9-fold larger (p = 0.006) and the number of metastases was higher in animals with tumors silenced for NDRG1 primarily (3 vs. 1.1; p = 0.005) and at recurrence (3.3 vs. 0.9; p = 0.015). CONCLUSION: NDRG1 may be an interesting therapeutic target as its silencing in human pancreatic cancer cells leads to a phenotype with more aggressive tumor growth and metastasis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Viszeralchirurgie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Viszeralchirurgie

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Visceral Surgery
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Physiology
04 Faculty of Medicine > Service Sector > Institute of Pathology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine

UniBE Contributor:

Kim-Fuchs, Corina; Winter, Annja; Malinka, Thomas; Born, Diana; Schäfer, Stephan; Keogh-Stroka, Deborah M.; Gloor, Beat and Candinas, Daniel

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

0253-4886

Publisher:

Karger

Language:

English

Submitter:

Lilian Karin Smith-Wirth

Date Deposited:

16 Apr 2015 15:23

Last Modified:

06 Nov 2015 09:48

Publisher DOI:

10.1159/000363065

PubMed ID:

24970329

Uncontrolled Keywords:

Pancreatic cancer, Orthotopic xenograft animal model of recurrence, N-myc downstream-regulated gene-1

BORIS DOI:

10.7892/boris.66948

URI:

https://boris.unibe.ch/id/eprint/66948

Actions (login required)

Edit item Edit item
Provide Feedback